Pulmonary Aspergillosis Invasive: Clinical Trials

2 trials for Pulmonary Aspergillosis Invasive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. .

Follow Pulmonary Aspergillosis Invasive: new trials by email Literature Review of Pulmonary Aspergillosis Invasive trials Research Report on Pulmonary Aspergillosis Invasive

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor Score
FUNGAL-P Score Assessment - Pneumonia, Fungal Pneumonia
RecruitingAzienda Ospedaliero-Universitaria Careggi4002025-11-132026-07-02
Incidence of Invasive Pulmonary Aspergillosis in Ventilator-associated Pneumonia
Biological examinations performed on blood and BAL - Ventilator Associated Pneumonia, Pulmonary Aspergillosis Invasive
CompletedUniversity Hospital, Lille2632023-08-282025-12-26

Narrower conditions

Invasive Pulmonary Aspergillosis (2)  ·  Coinfection (1)  ·  Communicable Diseases (1)  ·  Community-Acquired Pneumonia (1)  ·  Cross Infection (1)  ·  Emergencies (1)  ·  Mycoses (1)  ·  Pneumonia (1)  ·  Pneumonia, Pneumocystis (1)  ·  Pneumonia, Ventilator-Associated (1)  ·  Pulmonary Aspergillosis (1)  ·  Respiratory Tract Infections (1)

Broader conditions

Aspergillosis (2)  ·  Bacterial Infections and Mycoses (2)  ·  Disease Attributes (2)  ·  Infections (2)  ·  Invasive Fungal Infections (2)  ·  Lung Diseases (2)  ·  Lung Diseases, Fungal (2)  ·  Pathologic Processes (2)  ·  Pathological Conditions, Signs and Symptoms (2)  ·  Respiratory Tract Diseases (2)  ·  Community-Acquired Infections (1)  ·  Healthcare-Associated Pneumonia (1)  ·  Iatrogenic Disease (1)  ·  Mycoses (1)  ·  Pneumocystis Infections (1)

Sponsors

Azienda Ospedaliero-Universitaria Careggi (1)  ·  University Hospital, Lille (1)

Countries

France (1)  ·  Italy (1)

Top investigators

Lorenzo Pelagatti, MD, PhD (1)